In 2030 there will be vaccines against cancer and cardiovascular diseases created from mRNA technology. mRNA can be harnessed to order cells to build molecules capable of repairing damaged organs.
It can also organize the immune response against a virus, improve blood circulation, fight hereditary diseases and even tumors. Moderna has announced that it is working on a vaccine capable of releasing a molecule that can rebuild heart blood vessels in those who have suffered a heart attack, in order to increase the chances of survival. The speed and versatility offered by the mRNA molecule and its engineering are taking important steps.